Crinetics Pharmaceuticals Inc Earnings

The next earnings date for Crinetics Pharmaceuticals Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Crinetics Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-1.23

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Crinetics Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$0	100.00%
05/07/2025	Before Market	$-1.04	-9.21%
02/26/2025	Before Market	$-0.88	1.33%
11/12/2024	After Market	$-0.96	-5.49%
08/08/2024	After Market	$-0.94	-9.30%
05/09/2024	After Market	$-0.93	-14.81%
02/28/2024	After Market	$-0.90	-4.65%
11/07/2023	After Market	$-1.01	-17.44%
08/08/2023	Before Market	$-0.94	-9.30%
05/04/2023	After Market	$-0.85	-4.94%
02/28/2023	After Market	$-0.84	-2.44%
11/14/2022	Before Market	$-0.78	6.02%
08/12/2022	Before Market	$-0.81	-20.90%
05/12/2022	After Market	$-0.71	-22.41%
03/30/2022	After Market	$-0.68	-9.68%
11/05/2021	Before Market	$-0.73	-1.39%
08/10/2021	After Market	$-0.70	-14.75%
05/06/2021	After Market	$-0.69	-4.55%
03/30/2021	After Market	$-0.66	-13.79%
11/06/2020	Before Market	$-0.56	-5.66%
08/07/2020	Before Market	$-0.53	7.02%
05/08/2020	Before Market	$-0.71	-12.70%
03/09/2020	After Market	$-0.60	11.76%
11/12/2019	After Market	$-0.60	-5.26%
08/13/2019	After Market	$-0.51	-10.87%
05/13/2019	After Market	$-0.37	9.76%
03/13/2019	After Market	$-0.35	14.63%
11/13/2018	After Market	$-0.38	-11.76%
08/30/2018	After Market	$-2.41	-731.03%
05/03/2018	---	$-0.42	---

More About Crinetics Pharmaceuticals Inc

Website

https://www.crinetics.com

Country

USA

Full Time Employees

437

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and cushing's disease; and CRN09682, a nonpeptide drug conjugate for SST2 positive solid tumors. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease; SST3 Agonist program for the treatment for autosomal dominant polycystic kidney disease; and Radionetics for multiple solid-tumors, as well as Oral GLP-1 and Oral GIP nonpeptides for the treatment of obesity. The company has an agreement with Sanwa Kagaku Kenkyusho Co., Ltd to develop and commercialize Paltusotine in Japan, and Cellular Longevity, Inc. to develop and commercialize CRN01941, a somatostatin receptor type 2 agonist. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

“Crinetics Pharmaceuticals Inc Earnings” Can Refer to the Crinetics Pharmaceuticals Inc Earnings Date

Some people say “Crinetics Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Crinetics Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Crinetics Pharmaceuticals Inc Stock on the Earnings Date

If you own Crinetics Pharmaceuticals Inc stock (CRNX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Crinetics Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Crinetics Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Crinetics Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Crinetics Pharmaceuticals Inc earnings or anything else related to the stock market.